Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Bioequivalence of intravenous and oral formulations of the antiepileptic drug lacosamide

Trial Profile

Bioequivalence of intravenous and oral formulations of the antiepileptic drug lacosamide

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Sep 2012

At a glance

  • Drugs Lacosamide (Primary) ; Lacosamide (Primary)
  • Indications Epilepsy; Fibromyalgia; Osteoarthritis; Pain; Sleep disorders; Tonic-clonic epilepsy
  • Focus Pharmacokinetics
  • Sponsors UCB Pharma AG
  • Most Recent Events

    • 20 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top